Sept. 20, 2021
by Andrii Buvailo, Irina Bilous
Biopharma insight
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a …
Sept. 28, 2020
by Andrii Buvailo
Interview
Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based …
Sept. 14, 2020
by Raj Indupuri
Biopharma insight
How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like …
Aug. 18, 2020
by Ivan Kondratov
Biopharma insight
Recently my favorite website ENDPOINTSNEWS published a rating of key players in the ongoing COVID-19 vaccine race. Compared to many …
July 11, 2020
by Andrii Buvailo
Biopharma insight
What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they …
July 2, 2020
by Andrii Buvailo
Interview
Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of …
June 12, 2020
by BiopharmaTrend
Undefined
In the Toughest of days amid a Pandemic like this, when the only certainty is uncertainty, World BI has decided to go …
June 12, 2020
by BiopharmaTrend
Undefined
In the Toughest of days amid a Pandemic like this, when the only certainty is uncertainty, World BI has decided to …
March 23, 2020
by David Shlaes
Biopharma insight
Coronaviruses are a large family of viruses that cause disease in animals and humans. They were discovered as a cause …
March 16, 2020
by Caroline Green
Biopharma insight
In a new study, researchers from the National Institutes of Health reported that the experimental antiviral drug remdesivir (also known as …
March 14, 2020
by Andrii Buvailo
Biopharma insight
UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs …